pentobarbital will decrease the extent or influence of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Keep away from coadministration of bedaquiline with powerful CYP3A4 inducers as a result of likely for lowered therapeutic resultpentobarbital will reduce the extent or outcome of toltero